Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Slc35a4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC35A4 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Slc35a4 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of SLC35A4 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SLC35A4 mRNA | CTD | PMID:22206623 | 14-Deoxy-11,12-didehydroandrographolide | decreases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of SLC35A4 mRNA | CTD | PMID:22101062 | 17alpha-ethynylestradiol | increases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of SLC35A4 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | affects expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of SLC35A4 mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | multiple interactions | ISO | Slc35a4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC35A4 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Slc35a4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC35A4 mRNA and [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC35A4 mRNA | CTD | PMID:17942748 and PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC35A4 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC35A4 mRNA | CTD | PMID:21215274 and PMID:33387578 | 2-methylcholine | affects expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of SLC35A4 mRNA | CTD | PMID:21179406 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of SLC35A4 mRNA | CTD | PMID:30047161 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SLC35A4 mRNA | CTD | PMID:30047161 | aflatoxin B1 | decreases methylation | ISO | SLC35A4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SLC35A4 gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SLC35A4 mRNA | CTD | PMID:33167477 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of SLC35A4 mRNA | CTD | PMID:30047161 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of SLC35A4 mRNA | CTD | PMID:30047161 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SLC35A4 mRNA | CTD | PMID:16483693 | aristolochic acid A | increases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of SLC35A4 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | multiple interactions | ISO | Slc35a4 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SLC35A4 mRNA] | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | SLC35A4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SLC35A4 promoter | CTD | PMID:30157460 | benzo[a]pyrene | increases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SLC35A4 mRNA | CTD | PMID:22228805 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SLC35A4 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC35A4 mRNA | CTD | PMID:34947998 | butanal | decreases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of SLC35A4 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | SLC35A4 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC35A4 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | SLC35A4 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC35A4 mRNA | CTD | PMID:35301059 | carbon nanotube | increases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | SLC35A4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLC35A4 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SLC35A4 mRNA | CTD | PMID:37019170 | cisplatin | decreases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SLC35A4 mRNA | CTD | PMID:27594783 | dicrotophos | increases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of SLC35A4 mRNA | CTD | PMID:28302478 | diuron | decreases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Diuron results in decreased expression of SLC35A4 mRNA | CTD | PMID:35967413 | epoxiconazole | decreases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SLC35A4 mRNA | CTD | PMID:35436446 | fenthion | increases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Fenthion results in increased expression of SLC35A4 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | Slc35a4 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of SLC35A4 mRNA] | CTD | PMID:22206623 | folic acid | decreases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SLC35A4 mRNA | CTD | PMID:25629700 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SLC35A4 mRNA | CTD | PMID:22061828 | ivermectin | decreases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SLC35A4 protein | CTD | PMID:32959892 | lead(0) | affects expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Lead affects the expression of SLC35A4 mRNA | CTD | PMID:28903495 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of SLC35A4 mRNA | CTD | PMID:30047161 | methotrexate | affects expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Methotrexate affects the expression of SLC35A4 mRNA | CTD | PMID:18502557 | N(4)-hydroxycytidine | decreases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | N(4)-hydroxycytidine results in decreased expression of SLC35A4 mRNA | CTD | PMID:37748715 | nickel atom | affects expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Nickel affects the expression of SLC35A4 mRNA | CTD | PMID:14575637 | nickel atom | multiple interactions | ISO | SLC35A4 (Homo sapiens) | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of SLC35A4 mRNA] | CTD | PMID:14575637 | paracetamol | affects expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SLC35A4 mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slc35a4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC35A4 mRNA | CTD | PMID:36331819 | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of SLC35A4 mRNA | CTD | PMID:30047161 | sodium arsenite | increases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SLC35A4 mRNA | CTD | PMID:34032870 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of SLC35A4 mRNA | CTD | PMID:30047161 | sunitinib | decreases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SLC35A4 mRNA | CTD | PMID:31533062 | tamoxifen | affects expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Tamoxifen affects the expression of SLC35A4 mRNA | CTD | PMID:17555576 | testosterone | decreases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of SLC35A4 mRNA | CTD | PMID:33359661 | titanium dioxide | increases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SLC35A4 mRNA | CTD | PMID:29264374 | trichostatin A | multiple interactions | ISO | SLC35A4 (Homo sapiens) | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of SLC35A4 mRNA] | CTD | PMID:14575637 | valproic acid | decreases expression | ISO | Slc35a4 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of SLC35A4 mRNA | CTD | PMID:21427059 | valproic acid | increases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC35A4 mRNA | CTD | PMID:23179753 | zidovudine | increases expression | ISO | SLC35A4 (Homo sapiens) | 6480464 | Zidovudine results in increased expression of SLC35A4 mRNA | CTD | PMID:24292225 | |